These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 21051916)
1. Macrophages acquire fibroblast characteristics in a rat model of proliferative vitreoretinopathy. Lin ML; Li YP; Li ZR; Lin JX; Zhou XL; Liang D Ophthalmic Res; 2011; 45(4):180-90. PubMed ID: 21051916 [TBL] [Abstract][Full Text] [Related]
2. Intraretinal immunohistochemistry findings in proliferative vitreoretinopathy with retinal shortening. Pastor JC; Méndez MC; de la Fuente MA; Coco RM; García-Arumí J; Rodríguez de la Rúa E; Fernández N; Saornil MA; Gayoso MJ Ophthalmic Res; 2006; 38(4):193-200. PubMed ID: 16679807 [TBL] [Abstract][Full Text] [Related]
3. EIU in the rat promotes the potential of syngeneic retinal cells injected into the vitreous cavity to induce PVR. Behar-Cohen FF; Thillaye-Goldenberg B; de Bizemont T; Savoldelli M; Chauvaud D; de Kozak Y Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3915-24. PubMed ID: 11053294 [TBL] [Abstract][Full Text] [Related]
4. Attenuated glial reaction in experimental proliferative vitreoretinopathy treated with liposomal doxorubicin. Kuo HK; Chen YH; Wu PC; Wu YC; Huang F; Kuo CW; Lo LH; Shiea J Invest Ophthalmol Vis Sci; 2012 Jun; 53(6):3167-74. PubMed ID: 22491400 [TBL] [Abstract][Full Text] [Related]
5. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells. Casaroli-Marano RP; Pagan R; Vilaró S Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2062-72. PubMed ID: 10440262 [TBL] [Abstract][Full Text] [Related]
6. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy. Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679 [TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical study on vitrectomy specimens of proliferative retinal diseases]. Cao J; Wu L; Zhang H Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):264-7. PubMed ID: 10451957 [TBL] [Abstract][Full Text] [Related]
8. Intravitreal daunomycin induces multidrug resistance in proliferative vitreoretinopathy. Esser P; Tervooren D; Heimann K; Kociok N; Bartz-Schmidt KU; Walter P; Weller M Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):164-70. PubMed ID: 9430558 [TBL] [Abstract][Full Text] [Related]
10. Tubular epithelial cells have the capacity to transdifferentiate into CD68-positive macrophage-like cells by oxidative stress. Tanaka M; Suzuki Y; Shirato I; Takahara H; Shibata T; Sugaya T; Shimamoto K; Horikoshi S; Tomino Y Inflamm Res; 2008 Dec; 57(12):593-600. PubMed ID: 19109740 [TBL] [Abstract][Full Text] [Related]
11. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF. Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409 [TBL] [Abstract][Full Text] [Related]
12. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy. Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of extracellular ATP-induced Müller cell responses in a dispase model of proliferative vitreoretinopathy. Francke M; Weick M; Pannicke T; Uckermann O; Grosche J; Goczalik I; Milenkovic I; Uhlmann S; Faude F; Wiedemann P; Reichenbach A; Bringmann A Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):870-81. PubMed ID: 11867610 [TBL] [Abstract][Full Text] [Related]
14. The activation of MEK-ERK1/2 by glutamate receptor-stimulation is involved in the regulation of RPE proliferation and morphologic transformation. Pacheco-Domínguez RL; Palma-Nicolas JP; López E; López-Colomé AM Exp Eye Res; 2008 Feb; 86(2):207-19. PubMed ID: 18061165 [TBL] [Abstract][Full Text] [Related]
15. Reactive spindle cell nodules of the breast. Reis-Filho JS; Schmitt FS Am J Clin Pathol; 2001 May; 115(5):781-2. PubMed ID: 11345844 [No Abstract] [Full Text] [Related]
16. Characterization of newly established tumor lines from a spontaneous malignant schwannoma in F344 rats: nerve growth factor production, growth inhibition by transforming growth factor-beta1, and macrophage-like phenotype expression. Yamate J; Yasui H; Benn SJ; Tsukamoto Y; Kuwamura M; Kumagai D; Sakuma S; LaMarre J Acta Neuropathol; 2003 Sep; 106(3):221-33. PubMed ID: 12811582 [TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. Andrews A; Balciunaite E; Leong FL; Tallquist M; Soriano P; Refojo M; Kazlauskas A Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2683-9. PubMed ID: 10509666 [TBL] [Abstract][Full Text] [Related]
18. Transdifferentiation of human monocytes into fibroblast-like cells in vitro. Reuter U; Champion C; Kain HL Ger J Ophthalmol; 1995 May; 4(3):182-7. PubMed ID: 7663332 [TBL] [Abstract][Full Text] [Related]
19. [Distribution of fibronectin in experimental traumatic proliferative vitreoretinopathy]. Jiang X; Zhang X Zhonghua Yan Ke Za Zhi; 1995 Sep; 31(5):363-5. PubMed ID: 8706586 [TBL] [Abstract][Full Text] [Related]
20. Circulating fibrocytes contribute to the myofibroblast population in proliferative vitreoretinopathy epiretinal membranes. Abu El-Asrar AM; Struyf S; Van Damme J; Geboes K Br J Ophthalmol; 2008 May; 92(5):699-704. PubMed ID: 18441176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]